Fellowship in Industry Program — BeiGene | UOP
Close
Breadcrumb
Fellowship in Industry Program — BeOne
Thomas J. Long School of Pharmacy
About
Events
Alumni
Support the School
Interactions Magazine
Annual Report
Continuing Education
Logo Use
Apply PharmD
How to Apply
App Deadlines
Prerequisites
FAQs
Technical Standards
Tuition & Financial Aid
Admitted PharmD Students
Academics
Pre-Pharmacy Advantage Program
BS in Pharmaceutical Science
MS in Regulatory Science
Doctor of Pharmacy
Pharmaceutical and Chemical Sciences
PharmD Outcomes Data
Jie Du Center
iCOR Research Center
Fellowships
BeOne
BridgeBio
Day One
Genentech
Gilead
Pharmacy Practice
Partner Therapeutics
U.S. Air Force
Directory
Pharmaceutical Sciences
Pharmacy Practice
Staff
Preceptor Corner
Noteworthy Submissions
Community
Medicare Part D Outreach Clinics
Community Impact - Medicare Part D
Diabetes Care Clinics
Thomas J. Long School of Pharmacy Fellowships
Partnership with BeOne
The Thomas J. Long School of Pharmacy is proud to partner with BeOne to offer a Fellowship in Industry Program (FIP). Founded in 2017, the program aims to provide exceptional biopharmaceutical industry training for doctor of pharmacy (PharmD) graduates. The goal of the program is to prepare fellows for a career in the pharmaceutical industry by focusing on developing technical, leadership and communication skills. The fellowship will also concentrate on cultivating the fellow's clinical skills while honing their expertise in their area of interest.
View the brochure
About BeOne
BeOne is a global biotechnology company that is discovering and developing innovative oncology treatments that are more affordable and accessible to cancer patients worldwide. From the beginning, BeOne’s Research & Development team has focused on advancing a pipeline that includes potentially first-in-class and best-in-class molecules. They are working toward this goal with one of the largest oncology research teams in the world, and a global clinical development organization that oversees dozens of clinical trials. The strength and quality of this work is validated by their clinical trial results, regulatory approvals, and collaborations.
BeOne takes an innovative approach that leverages biology and scale.  Our approach to cancer biology unites cutting-edge research models and processes for drug discovery with the scale of a global organization. We are particularly interested in immuno-oncology, a cornerstone of cancer treatments. There is tremendous potential for synergistic combinations of cancer immunotherapies, and for combining cancer immunotherapies with other therapies.
Learn more about BeOne
This two-year Hematology-Oncology Clinical Development fellowship provides extensive exposure to clinical development activities and fosters an understanding of clinical research principles. The fellow will function as a Clinical Scientist and will support Medical Directors/senior-level Clinical Scientists on a diverse set of clinical development activities.
BeOne has built an extensive array of novel in vitro, ex vivo and in vivo cancer models to help better select targets, and to screen and evaluate agents that may have significant potential (alone or in combination). By integrating elements of the human immune system, their cancer models enable them to evaluate potential drug candidates in conditions that mimic cancer at the time of treatment. This is especially significant when drug discovery depends on evaluating multiple combinations and regimens that target specific mutations while simultaneously immobilizing cancer cells’ defenses. In the role of a Clinical Scientist, the fellow will gain a strong foundation in clinical oncology research.
Activities at BeOne:
The fellow will function as a clinical scientist and will support medical directors/senior level clinical scientists on the following activities:
Serve as a clinical science representative on cross-functional sub-teams (i.e. protocol execution, clinical, biomarkers, pharmacokinetics)
Create, review and present clinical slides for internal (i.e. BeOne) and external meetings (e.g. Investigator meetings, scientific congresses, advisory boards, site visits, site staff training)
Develop understanding of Good Clinical Practice (GCP), International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH), FDA, EMA, NICE and other relevant guidelines and regulations
Draft abstracts, posters, manuscripts for scientific meetings
Author and review of clinical documents (i.e. clinical trial protocols, clarifications and amendments, informed consents, investigator brochures, clinical study reports, investigational new drug submissions)
Respond to inquiries from health authorities (e.g. FDA, EMA) and study site ethics committees
Partner with the data management team to assist with the development of case report forms
Serve as a primary point of contact for study inquiries
Contribute to ongoing review of the integrity of clinical trial data
Develop understanding of the entire clinical development process from Phase I-IV
Fellowship Program Dates
The fellowship begins
July 1, 2025
and ends
June 30, 2027
Fellowship Eligibility Requirements
A candidate must be:
A permanent resident or citizen of the United States
PharmD from an accredited college or university before the start of the fellowship term
Application Process
Candidates must submit the following application materials to
pharmfip@pacific.edu
Letter of intent
Curriculum vitae (CV)
Three (3) letters of recommendation emailed directly from the letter writer
One professional writing sample
Unofficial pharmacy school transcript
Application Deadline
Not currently recruiting.
Submit to
pharmfip@pacific.edu
Fellowship showcases non-traditional career path
This two-year fellowship was designed to give a PharmD graduate exceptional training in clinical development within the hematology-oncology space and was launched by two alumni,
Sheel Patel ’16
’19
, PharmD and
Andy Szeto ’18
, PharmD.
Fellowship in Industry Program
Sachin A. Shah, PharmD, FACC, FAHA
Director, Fellowship in Industry Program
Professor of Pharmacy Practice
University of the Pacific
Thomas J. Long School of Pharmacy
3601 Pacific Ave., Stockton, CA 95211
pharmfip@pacific.edu
209.946.7754
More Fellowships
Gilead
Genentech
More Fellowships
Day One
Partner Therapeutics
Make your gift
Close Search